| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Todisco Joseph | Chief Executive Officer | C/O CORMEDIX INC., 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS | /s/ Joseph Todisco | 12 Sep 2025 | 0001774807 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRMD | Common Stock | Options Exercise | $173,500 | +50,000 | +9.8% | $3.47 | 559,496 | 12 Sep 2025 | Direct | |
| transaction | CRMD | Common Stock | Sale | $650,000 | -50,000 | -8.9% | $13.00 | 509,496 | 12 Sep 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | $0 | -50,000 | -19% | $0.000000 | 216,667 | 12 Sep 2025 | Common Stock | 50,000 | $3.47 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $12.82 to $13.27. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F2 | These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |